Abstract:Introduction: Breast cancer (BC) remains a leading cause of cancer-associated mortality for women in the USA, which makes it critically important to identify and study molecular drivers of pathogenesis. We have previously identified the chromatin modifying DEK protein to have oncogenic properties. DEK is a histone H3 chaperone that is over-expressed in over 60% of breast cancers, particularly triple negative breast cancers, and is associated with poor survival. To date, all studies regarding the role of DEK in BC have manipulated DEK expression in cultured immortalized MCF10A human mammary epithelial cells and BC cell lines. However, the oncogenic functions of DEK in vivo and in normal mammary epithelium have remained unexplored. Methods: We utilized a tetracycline-off regulated, DEK overexpressing (DEK-OE) transgenic mouse model that targets mammary epithelium through the mouse mammary tumor virus (MMTV) promoter. We subsequently performed bulk RNA-Seq transcriptomic analyses, western blotting, and both histological and morphological assessments of control vs. DEK-OE mammary gland tissue to identify the oncogenic effects of DEK over-expression in vivo. Results: Bulk RNA sequencing and gene ontology analyses identified cell cycle regulation as a significantly upregulated biological process in DEK-OE versus control glands. Subsequent studies confirmed upregulation of proteins that promote the G1-S cell cycle transition including cyclins A and D and CDKs 2, 4, and 6 as well as increased numbers of Ki67+ cells. We also observed down-regulation of genes that inhibit entry the G1-S transition, such as p21 and p27. This pro-proliferative molecular status correlated with the development of mammary gland hyperplasia. Importantly, in silico analyses demonstrated gene correlations between DEK and cell cycle regulators that were also evident in human breast cancers. One potential mechanism for this transcriptional deregulation is that we identified increased histone H3K27me3 epigenetic modifications in DEK-OE cells, in both mouse and human models, which may occur through EZH2 activity. Conclusions: Combined, our work indicates that DEK is not a tumor initiator, but its oncogenic activities are likely due to its ability to promote proliferation of mammary epithelial cells. Furthermore, we report a novel function for DEK in the epigenetic regulation of histone H3 K27 trimethylation, which is mediated by the well-known EZH2 oncogene in triple negative breast cancers. Citation Format: Megan Johnstone, Ashley Leck, Taylor Lange, Lisa Privette Vinnedge. DEK overexpression in the murine mammary gland promotes epithelial hyperplasia [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Breast Cancer Research; 2023 Oct 19-22; San Diego, California. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_1) nr A084.

The chromatin remodeler DEK promotes proliferation of mammary epithelium and is associated with H3K27me3 epigenetic modifications

Abstract A084: DEK overexpression in the murine mammary gland promotes epithelial hyperplasia

The histone demethylase KDM6A controls the mammary luminal lineage through enzyme-independent mechanisms.

Nuclear DEK Preserves Hematopoietic Stem Cells Potential Via NCoR1/HDAC3-Akt1/2-mTOR Axis

DEK promoted EMT and angiogenesis through regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer

Conditional Deletion of Shp2 in the Mammary Gland Leads to Impaired Lobulo-Alveolar Outgrowth and Attenuated Stat5 Activation.

Bacterial Growth Inhibition Screen (BGIS) identifies a loss-of-function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin

The Dek Protein - an Abundant and Ubiquitous Constituent of Mammalian Chromatin

The DEK Oncogene Activates VEGF Expression and Promotes Tumor Angiogenesis and Growth in HIF-1α-dependent and -Independent Manners.

Increased Expression of Cyclin D1 in a Murine Mammary Epithelial Cell Line Induces P27kip1, Inhibits Growth, and Enhances Apoptosis.

Deletion of Tip30 Leads to Rapid Immortalization of Murine Mammary Epithelial Cells and Ductal Hyperplasia in the Mammary Gland

BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A

Integrated Single-Cell Transcriptomics and Chromatin Accessibility Analysis Reveals Novel Regulators of Mammary Epithelial Cell Identity

Ehf controls mammary alveolar lineage differentiation and is a putative suppressor of breast tumorigenesis

Conditional knockout of N-Myc and STAT interactor disrupts normal mammary development and enhances metastatic ability of mammary tumors

DEK Modulates Both Expression and Alternative Splicing of Cancer-Related Genes

Secreted Nuclear Protein DEK Regulates Hematopoiesis Through CXCR2 Signaling

Roles of DEK in the Endometrium of Mice in Early Pregnancy

The molecular chronology of mammary epithelial cell fate switching

On growth and form of the mouse mammary gland

Kinase-independent Role of Cyclin D1 in Chromosomal Instability and Mammary Tumorigenesis.